Clinical Trial Update: A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection [Phase 2]

View source ↗

Summary

A Phase 2 long-term follow-up study assessing whether lumicitabine affects the incidence of asthma and/or wheezing in infants and children after RSV infection; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Respiratory Syncytial Virus Infections
• Wheezing Disorders in Children

Drugs mentioned

• Lumicitabine (lumicitabine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-04-13